Latest Headlines

Acorda Therapeutics Inc (ACOR) Analysts See $0.15 EPS

Marguerite Chambers

Investors sentiment increased to 0.99 in Q4 2016. Its up 0.10, from 0.89 in 2016Q3. It improved, as 17 investors sold Acorda Therapeutics Inc shares while 56 reduced holdings. 25 funds opened positions while 47 raised stakes. 46.53 million shares or 2.03% less from 47.49 million shares in 2016Q3 were reported. Louisiana ...